Ignite Creation Date:
2025-12-25 @ 3:55 AM
Ignite Modification Date:
2025-12-26 @ 2:46 AM
Study NCT ID:
NCT00765102
Status:
TERMINATED
Last Update Posted:
2019-11-25
First Post:
2008-09-30
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Trial of Romidepsin and Bortezomib for Multiple Myeloma
Sponsor:
Celgene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-09-01
Start Date Type:
ACTUAL
Primary Completion Date:
2010-03-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-03-01
Completion Date Type:
ACTUAL
First Submit Date:
2008-09-30
First Submit QC Date:
None
Study First Post Date:
2008-10-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-09-26
Results First Submit QC Date:
None
Results First Post Date:
2012-12-20
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-14
Last Update Post Date:
2019-11-25
Last Update Post Date Type:
ACTUAL